BMY
Bristol-Myers Squibb Company
61.20$
-1.8%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +4.7% | +3.4% | +2.8% | -2.5% | +3.8% | -9.2% | +9.5% | -0.4% | +2.3% | -8.1% | +12.9% | – | |
| – | +5.0% | +5.8% | +2.4% | -2.3% | -6.8% | -38.3% | +11.2% | +1.9% | +19.3% | -16.5% | +8.9% | – | |
| – | +4.4% | +1.5% | +3.2% | -2.7% | +12.2% | +10.0% | +8.9% | -1.2% | -4.3% | -4.0% | +14.6% | – | |
| – | +13.7% | +8.8% | -14.8% | +2.5% | +18.5% | -19.0% | +14.3% | -2.0% | +2.3% | +2.4% | +11.7% | – | |
| – | -65.7% | +256.5% | -18.5% | +2.9% | -82.2% | +350.0% | +8.1% | +4.4% | +21.9% | -25.9% | +12.9% | – | |
| – | +10.3% | +11.3% | -16.6% | +2.7% | +13.0% | -4.5% | +9.7% | +0.5% | +8.6% | -15.9% | +9.7% | – | |
| – | -7.2% | -21.4% | +68.3% | -11.5% | +10.6% | +38.2% | +7.9% | -3.6% | -22.7% | +19.6% | +21.4% | – | |
| – | +12.9% | +34.5% | +22.6% | -3.1% | -1.8% | -0.4% | -1.8% | -1.0% | -10.0% | -4.9% | -1.0% | – | |
| – | -21.7% | -787.9% | – | +30.3% | -89.6% | +1,597.7% | -40.3% | +75.6% | -52.8% | +120.4% | +26.1% | – | |
| – | -143.3% | – | -201.5% | – | -78.5% | +414.1% | -9.6% | +99.8% | -58.2% | +46.1% | +37.3% | – | |
| – | -8.6% | -776.0% | – | -27.9% | -94.1% | +3,311.1% | -46.7% | +68.0% | -50.6% | +146.3% | +23.9% | – | |
| – | -8.2% | -292.2% | – | +8.4% | -46.6% | +75.5% | -27.0% | +40.9% | -37.5% | +47.4% | +16.4% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.